Are corticosteroids indicated for acute decompensation of chronic liver disease, and if so, in which specific situations?

Corticosteroids in Acute Decompensation of Chronic Liver Disease

Corticosteroids are NOT routinely indicated for acute decompensation of chronic liver disease, with the critical exception of severe alcohol-associated hepatitis (Maddrey score ≥32) where prednisolone 40 mg/day for 28 days improves short-term survival. 1

Specific Clinical Scenarios

Alcohol-Associated Hepatitis (Severe)

This is the PRIMARY indication for corticosteroids in acute decompensation:

When to Use:

• Maddrey Discriminant Function (mDF) ≥32, OR
• MELD >20-21, OR
• Glasgow Alcoholic Hepatitis Score (GAHS) ≥9
• With or without hepatic encephalopathy 1, 2, 3

Regimen:

• Prednisolone 40 mg/day (or methylprednisolone 32 mg/day) for 28 days 1
• Assess response at day 7 using Lille score
• If Lille <0.45: continue full 28-day course
• If Lille ≥0.45: discontinue steroids (non-responders) 3

Contraindications:

• Uncontrolled infection
• Active gastrointestinal bleeding
• Acute kidney injury with creatinine >2.5 mg/dL
• Acute pancreatitis
• Multiorgan failure 2, 3

Evidence: The 2022 French guidelines 1 and 2020 AASLD guidance 3 both strongly recommend corticosteroids for severe alcohol-associated hepatitis based on individual patient data meta-analysis of 2,111 patients showing improved 1-month survival. However, the survival benefit disappears by 3 months, highlighting the need for additional therapies.

Autoimmune Hepatitis (Acute Severe Presentation)

When to Use:

• Acute severe AIH with INR >1.5 but <2.0
• WITHOUT hepatic encephalopathy grade III-IV
• WITHOUT acute liver failure (ALF) features 4

Regimen:

• Prednisolone 0.5-1 mg/kg/day (or IV methylprednisolone equivalent)
• Start EARLY, ideally before encephalopathy develops
• Assess response at days 3-7 4

When NOT to Use:

• Acute severe AIH WITH hepatic encephalopathy grade III-IV → refer for urgent liver transplant instead 5
• Acute liver failure (INR >2.0 with encephalopathy) → transplant evaluation, NOT steroids 4

Critical Distinction: The 2025 EASL AIH guidelines 4 emphasize that patients with acute severe AIH WITHOUT fulminant features have transplant-free survival of 52-95% with steroids, but those with ALF/ACLF have only 8-41% response rates and should proceed directly to transplant evaluation.

Acute-on-Chronic Liver Failure (ACLF)

Corticosteroids are NOT recommended for ACLF in general 6, 7. The exception is when ACLF is precipitated by:

• Severe alcohol-associated hepatitis (as above)
• Acute severe autoimmune hepatitis (without ALF features)

Key Point: A 2014 multicenter study 8 of 361 ALF patients found steroids did NOT improve overall survival and were associated with LOWER survival in patients with MELD >40 (30% vs 57%, p=0.03). This applies to drug-induced, indeterminate, and even autoimmune ALF.

Other Causes of Acute Decompensation

DO NOT USE corticosteroids for:

• Hepatitis B flare/reactivation → use antivirals, NOT steroids 9
• Drug-induced liver injury → withdraw drug; steroids do NOT hasten resolution and may delay recovery 10
• Ischemic hepatitis ("shock liver") → treat underlying cause
• Acute fatty liver of pregnancy → deliver, NOT steroids
• Wilson's disease → copper reduction/transplant, NOT steroids 11

Common Pitfalls

1. Using steroids in unrecognized infection: Always screen with chest X-ray, blood/urine/ascites cultures BEFORE starting steroids 3

2. Continuing steroids in non-responders: If Lille score ≥0.45 at day 7, STOP steroids—they increase infection risk without benefit 1

3. Using steroids for "general" decompensation: Steroids only work for specific inflammatory conditions (severe alcohol-associated hepatitis, acute severe AIH), NOT for decompensated cirrhosis in general 7

4. Delaying transplant evaluation: In severe cases (MELD >35, coma grade 4), steroids are futile—proceed directly to transplant evaluation 12

5. Confusing acute severe AIH with ALF: INR >2.0 with encephalopathy = ALF → transplant, NOT steroids 4

Algorithm Summary

Acute Decompensation of CLD
↓
Identify Etiology
↓
├─ Severe Alcohol-Associated Hepatitis (mDF ≥32)
│  ├─ No contraindications → Prednisolone 40 mg/day × 28 days
│  └─ Assess Lille at day 7 → Continue if <0.45, stop if ≥0.45
│
├─ Acute Severe AIH (INR 1.5-2.0, no encephalopathy III-IV)
│  └─ Prednisolone 0.5-1 mg/kg/day, assess at days 3-7
│
├─ AIH with ALF (INR >2.0 + encephalopathy)
│  └─ Urgent transplant evaluation, NOT steroids
│
└─ Other causes (HBV, DILI, ischemic, ACLF)
   └─ NO steroids; treat underlying cause

Bottom Line: Corticosteroids have a narrow, evidence-based role limited to severe alcohol-associated hepatitis and acute severe autoimmune hepatitis without fulminant features. For all other causes of acute decompensation, steroids are ineffective or harmful.